COURTNEY MATTHEWS: Open Payments
NPI 1952153629 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,547 in 66 payments from 29 companies in 2025. Trend: 2023 $0 · 2024 $1,040 · 2025 $1,547
Food & beverage: $1,372Education: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $153 |
| Daiichi Sankyo Inc. | 7 | $139 |
| Novartis Pharmaceuticals Corporation | 6 | $130 |
| Janssen Biotech, Inc. | 2 | $105 |
| SEAGEN INC. | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 4 | $98 |
| Incyte Corporation | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Aveo Pharmaceuticals, Inc. | 3 | $65 |
Products named: Enhertu, VENCLEXTA, RYBREVANT, SCEMBLIX, KEYTRUDA, FOTIVDA, KISQALI, LIBTAYO.
Industry payments across PA — which companies pay providers there.
